regeneron pharmaceuticals inc]
PUBLISHED ON FEB 25, 2021 05:45 PM IST
The Regeneron treatment is part of a class of drugs known as monoclonal antibodies.
Hindustan Times, Nrew Delhi | By hindustantimes.com | Edited by Shivani Kumar
UPDATED ON OCT 03, 2020 10:02 AM IST
Trump was given the experimental antibody drug by Regeneron Pharmaceuticals Inc, which has been described as one of the most promising approaches to preventing serious illness from a Covid-19 infection.
Reuters | By Reuters| Posted by Susmita Pakrasi
PUBLISHED ON SEP 30, 2020 05:23 AM IST
REGN-COV2 is part of a class of biotech therapies known as monoclonal antibodies. Several companies are using the technology to manufacture copies of human antibodies to the new coronavirus.